Clinical trial

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

NCT01443078

Study summary

ClinicalTrials.gov

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record pemetrexed Normalized identity: pemetrexed View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cisplatin Normalized identity: cisplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gemcitabine Hydrochloride Normalized identity: gemcitabine hydrochloride View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Vinorelbine Tartrate Normalized identity: vinorelbine tartrate View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Docetaxel Normalized identity: docetaxel View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-10-01

PhasePHASE2

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

pemetrexedDRUG · verified · RxNorm: pemetrexed

cisplatinDRUG · verified · RxNorm: cisplatin

CarboplatinDRUG · verified · RxNorm: carboplatin

Gemcitabine HydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride

Vinorelbine TartrateDRUG · verified · RxNorm: vinorelbine tartrate

DocetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

Eli Lilly and Companycollaborator

United States Department of Defensecollaborator

Mapped research locations

New YorkNew York, United States1 CommackNew York, United States1 Basking RidgeNew Jersey, United States1 Rockville CentreNew York, United States1 Sleepy HollowNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01443078 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.